SYK · News · 20261103N
Guidance / Outlook
STRYKER CORP · 2026-11-03 · Importance 62 · Surprise 68 · In source text
Third-party reporting says Stryker lowered its 2026 organic sales growth forecast to 6.5%–7.0%. The reported slowdown reflects broader market deceleration and slower market-share gains in Orthopaedics, including hips and knees. The report also cites the SAP system rollout as a factor affecting the team’s ability to capture market share.
Key facts
- Stryker reduced its full-year organic sales growth guidance to 6.5% to 7.0%. source
- Stryker's slower Orthopaedics growth led management to lower its 2026 organic sales growth forecast. source
- Future organic sales growth is a key metric for incoming CEO Spencer Stiles. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | committed | — | Stryker reduced its full-year organic sales growth guidance to 6.5% to 7.0%. |